GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » Net Policyholder Benefits/Claims

Medigene AG (WBO:MDG1) Net Policyholder Benefits/Claims


View and export this data going back to 2017. Start your Free Trial

What is Medigene AG Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Medigene AG (WBO:MDG1) Business Description

Industry
Traded in Other Exchanges
Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.